Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression
ConditionGlaucoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-90
SponsorCentervue SpA
About this trial
The purpose of this observational study is to collect over time a series of data in patients with glaucoma in order to evaluate different approaches in defining the progression of this pathology. These data will be collected in repeated visits over a 36-months follow-up period. At each visit, the COMPASS fundus perimeter and the Humphrey Field Analyzer (HFA) perimeter will be used to assess retinal functionality; an Optical Coherence Tomography (OCT) examination will also be performed to evaluate and obtain clinical information about the structure of the retina.
Eligibility criteria
Qualifiers
Glaucomatous optic nerve head in both eyes;
Age between 40 and 90 years;
Best Corrected Visual Acuity ≤ 0.3 [logMar];
Spherical refraction between -6D and +6D;
Disqualifiers
Any ocular surgery, except for: uncomplicated cataract surgery and/or glaucoma surgery in both eyes performed within 6 months before enrollment;
Any ocular pathology that can affect visual field other than glaucoma;
Use of any drug that can interfere with the correct execution of perimetry or that would produce visual field loss;
Inability to obtain reliable perimetric examinations;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov